Fig. 8
From: FEN1 plays a key role in the transition from HSIL to CSCC

The high level of FEN1 indicates the adverse reaction of SCC to immunotherapy. (A) Immune rejection score. (B) MDSC level. (C) Correlation between FEN1 expression and immune checkpoint inhibitor expression. (D) FEN1 docks with small molecule inhibitors. *P < 0.05.